Claim Your Free
Staff Education Wallboard!

Email-id is invalid

For latest News and updates

Allergy Cardiology Critical Care Dermatology Diabetes Emergency Gastroenterology Infectious Disease Neurology Nephrology OBGYN Oncology Opththalmology Pain Pediatrics Primary Care Pulmonology Psychiatry Rheumatology Surgery

SaveNot Now

Please select specialty

SaveNot Now

Home
Specialties
Meetings
CME/CE
Business of Medicine
Doctor’s Voice
Podcast

Select Page

Home »

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

Aug 5, 2022

Contributor: Teddy Guo

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

Click to read this study in The Lancet Oncology.

Sitemap

Meeting Coverage
Doctor’s Voice
Podcast
Continuing Education
Cartoons

About Physician's Weekly

About Us
Partners
Advertiser
Contact Us
Privacy Policy
Terms Of Use

For latest news and updates

Email-id is invalid

Claim Your Free Staff Education Wallboard!

Please select specialty

#VisualAbstract: Maintenance endocrine therapy plus bevacizumab after induction with paclitaxel is effective for ER+ breast cancers

Contributor: Teddy Guo

Leave a Reply Cancel reply

Claim Your Free
Staff Education Wallboard!